Domperidone, a dopamine D2 receptor antagonist, is known to promote cell-mediated immunity in dogs in which it reduces the risk for seronegative patients to develop an active infection and improves clinical signs and disease progression in already affected patients [77,78]. The gene discussed is DRD2; the disease is infection.